Cargando…
High Levels of Adherence and Viral Suppression in a Nationally Representative Sample of HIV-Infected Adults on Antiretroviral Therapy for 6, 12 and 18 Months in Rwanda
BACKGROUND: Generalizable data are needed on the magnitude and determinants of adherence and virological suppression among patients on antiretroviral therapy (ART) in Africa. METHODS: We conducted a cross-sectional survey with chart abstraction, patient interviews and site assessments in a nationall...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541229/ https://www.ncbi.nlm.nih.gov/pubmed/23326462 http://dx.doi.org/10.1371/journal.pone.0053586 |
_version_ | 1782255324956196864 |
---|---|
author | Elul, Batya Basinga, Paulin Nuwagaba-Biribonwoha, Harriet Saito, Suzue Horowitz, Deborah Nash, Denis Mugabo, Jules Mugisha, Veronicah Rugigana, Etienne Nkunda, Richard Asiimwe, Anita |
author_facet | Elul, Batya Basinga, Paulin Nuwagaba-Biribonwoha, Harriet Saito, Suzue Horowitz, Deborah Nash, Denis Mugabo, Jules Mugisha, Veronicah Rugigana, Etienne Nkunda, Richard Asiimwe, Anita |
author_sort | Elul, Batya |
collection | PubMed |
description | BACKGROUND: Generalizable data are needed on the magnitude and determinants of adherence and virological suppression among patients on antiretroviral therapy (ART) in Africa. METHODS: We conducted a cross-sectional survey with chart abstraction, patient interviews and site assessments in a nationally representative sample of adults on ART for 6, 12 and 18 months at 20 sites in Rwanda. Adherence was assessed using 3- and 30-day patient recall. A systematically selected sub-sample had viral load (VL) measurements. Multivariable logistic regression examined predictors of non-perfect (<100%) 30-day adherence and detectable VL (>40 copies/ml). RESULTS: Overall, 1,417 adults were interviewed and 837 had VL measures. Ninety-four percent and 78% reported perfect adherence for the last 3 and 30 days, respectively. Eighty-three percent had undetectable VL. In adjusted models, characteristics independently associated with higher odds of non-perfect 30-day adherence were: being on ART for 18 months (vs. 6 months); younger age; reporting severe (vs. no or few) side effects in the prior 30 days; having no documentation of CD4 cell count at ART initiation (vs. having a CD4 cell count of <200 cells/µL); alcohol use; and attending sites which initiated ART services in 2003–2004 and 2005 (vs. 2006–2007); sites with ≥600 (vs. <600 patients) on ART; or sites with peer educators. Participation in an association for people living with HIV/AIDS; and receiving care at sites which regularly conduct home-visits were independently associated with lower odds of non-adherence. Higher odds of having a detectable VL were observed among patients at sites with peer educators. Being female; participating in an association for PLWHA; and using a reminder tool were independently associated with lower odds of having detectable VL. CONCLUSIONS: High levels of adherence and viral suppression were observed in the Rwandan national ART program, and associated with potentially modifiable factors. |
format | Online Article Text |
id | pubmed-3541229 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-35412292013-01-16 High Levels of Adherence and Viral Suppression in a Nationally Representative Sample of HIV-Infected Adults on Antiretroviral Therapy for 6, 12 and 18 Months in Rwanda Elul, Batya Basinga, Paulin Nuwagaba-Biribonwoha, Harriet Saito, Suzue Horowitz, Deborah Nash, Denis Mugabo, Jules Mugisha, Veronicah Rugigana, Etienne Nkunda, Richard Asiimwe, Anita PLoS One Research Article BACKGROUND: Generalizable data are needed on the magnitude and determinants of adherence and virological suppression among patients on antiretroviral therapy (ART) in Africa. METHODS: We conducted a cross-sectional survey with chart abstraction, patient interviews and site assessments in a nationally representative sample of adults on ART for 6, 12 and 18 months at 20 sites in Rwanda. Adherence was assessed using 3- and 30-day patient recall. A systematically selected sub-sample had viral load (VL) measurements. Multivariable logistic regression examined predictors of non-perfect (<100%) 30-day adherence and detectable VL (>40 copies/ml). RESULTS: Overall, 1,417 adults were interviewed and 837 had VL measures. Ninety-four percent and 78% reported perfect adherence for the last 3 and 30 days, respectively. Eighty-three percent had undetectable VL. In adjusted models, characteristics independently associated with higher odds of non-perfect 30-day adherence were: being on ART for 18 months (vs. 6 months); younger age; reporting severe (vs. no or few) side effects in the prior 30 days; having no documentation of CD4 cell count at ART initiation (vs. having a CD4 cell count of <200 cells/µL); alcohol use; and attending sites which initiated ART services in 2003–2004 and 2005 (vs. 2006–2007); sites with ≥600 (vs. <600 patients) on ART; or sites with peer educators. Participation in an association for people living with HIV/AIDS; and receiving care at sites which regularly conduct home-visits were independently associated with lower odds of non-adherence. Higher odds of having a detectable VL were observed among patients at sites with peer educators. Being female; participating in an association for PLWHA; and using a reminder tool were independently associated with lower odds of having detectable VL. CONCLUSIONS: High levels of adherence and viral suppression were observed in the Rwandan national ART program, and associated with potentially modifiable factors. Public Library of Science 2013-01-09 /pmc/articles/PMC3541229/ /pubmed/23326462 http://dx.doi.org/10.1371/journal.pone.0053586 Text en © 2013 Elul et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Elul, Batya Basinga, Paulin Nuwagaba-Biribonwoha, Harriet Saito, Suzue Horowitz, Deborah Nash, Denis Mugabo, Jules Mugisha, Veronicah Rugigana, Etienne Nkunda, Richard Asiimwe, Anita High Levels of Adherence and Viral Suppression in a Nationally Representative Sample of HIV-Infected Adults on Antiretroviral Therapy for 6, 12 and 18 Months in Rwanda |
title | High Levels of Adherence and Viral Suppression in a Nationally Representative Sample of HIV-Infected Adults on Antiretroviral Therapy for 6, 12 and 18 Months in Rwanda |
title_full | High Levels of Adherence and Viral Suppression in a Nationally Representative Sample of HIV-Infected Adults on Antiretroviral Therapy for 6, 12 and 18 Months in Rwanda |
title_fullStr | High Levels of Adherence and Viral Suppression in a Nationally Representative Sample of HIV-Infected Adults on Antiretroviral Therapy for 6, 12 and 18 Months in Rwanda |
title_full_unstemmed | High Levels of Adherence and Viral Suppression in a Nationally Representative Sample of HIV-Infected Adults on Antiretroviral Therapy for 6, 12 and 18 Months in Rwanda |
title_short | High Levels of Adherence and Viral Suppression in a Nationally Representative Sample of HIV-Infected Adults on Antiretroviral Therapy for 6, 12 and 18 Months in Rwanda |
title_sort | high levels of adherence and viral suppression in a nationally representative sample of hiv-infected adults on antiretroviral therapy for 6, 12 and 18 months in rwanda |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541229/ https://www.ncbi.nlm.nih.gov/pubmed/23326462 http://dx.doi.org/10.1371/journal.pone.0053586 |
work_keys_str_mv | AT elulbatya highlevelsofadherenceandviralsuppressioninanationallyrepresentativesampleofhivinfectedadultsonantiretroviraltherapyfor612and18monthsinrwanda AT basingapaulin highlevelsofadherenceandviralsuppressioninanationallyrepresentativesampleofhivinfectedadultsonantiretroviraltherapyfor612and18monthsinrwanda AT nuwagababiribonwohaharriet highlevelsofadherenceandviralsuppressioninanationallyrepresentativesampleofhivinfectedadultsonantiretroviraltherapyfor612and18monthsinrwanda AT saitosuzue highlevelsofadherenceandviralsuppressioninanationallyrepresentativesampleofhivinfectedadultsonantiretroviraltherapyfor612and18monthsinrwanda AT horowitzdeborah highlevelsofadherenceandviralsuppressioninanationallyrepresentativesampleofhivinfectedadultsonantiretroviraltherapyfor612and18monthsinrwanda AT nashdenis highlevelsofadherenceandviralsuppressioninanationallyrepresentativesampleofhivinfectedadultsonantiretroviraltherapyfor612and18monthsinrwanda AT mugabojules highlevelsofadherenceandviralsuppressioninanationallyrepresentativesampleofhivinfectedadultsonantiretroviraltherapyfor612and18monthsinrwanda AT mugishaveronicah highlevelsofadherenceandviralsuppressioninanationallyrepresentativesampleofhivinfectedadultsonantiretroviraltherapyfor612and18monthsinrwanda AT rugiganaetienne highlevelsofadherenceandviralsuppressioninanationallyrepresentativesampleofhivinfectedadultsonantiretroviraltherapyfor612and18monthsinrwanda AT nkundarichard highlevelsofadherenceandviralsuppressioninanationallyrepresentativesampleofhivinfectedadultsonantiretroviraltherapyfor612and18monthsinrwanda AT asiimweanita highlevelsofadherenceandviralsuppressioninanationallyrepresentativesampleofhivinfectedadultsonantiretroviraltherapyfor612and18monthsinrwanda |